#277 ‒ Food allergies: causes, prevention, and treatment with immunotherapy | Kari Nadeau, M.D., Ph.D.

Episode Summary

Executive Summary: Peter Attia interviews Dr. Keri Nadeau about the immunology of food allergy, distinguishing true IgE-mediated allergy from food sensitivity and celiac disease, and explaining how early exposure, skin barrier health, and environmental factors shape risk. They also cover oral immunotherapy for food allergy, the importance of epinephrine preparedness, and the health impact of PM2.5 air pollution.

Main Topics: Immune system fundamentals (Priority: 5/5): Nadeau explains how innate and adaptive immunity work together, including macrophages, T cells, B cells, and immunoglobulins (IgG, IgA, IgM, IgE), to fight infections and create immune memory. Food sensitivity vs food allergy vs celiac disease (Priority: 5/5): The discussion distinguishes non-IgE food sensitivities (often causing bloating, headaches, inflammation) from true IgE-mediated food allergy and from celiac disease, which is a specific immune reaction to gluten-related proteins. Why food allergies develop (Priority: 5/5): Nadeau describes environmental drivers such as dry skin/barrier dysfunction, detergents, pollution, low vitamin D, and lack of early dietary diversity, emphasizing that most food allergy risk is not purely genetic. Oral immunotherapy and desensitization (Priority: 5/5): They discuss how carefully dosed daily exposure to allergenic foods can retrain the immune system, reduce IgE-driven reactions, and increase tolerance, with protocols now used clinically beyond trials. Anaphylaxis prevention and epinephrine use (Priority: 5/5): The episode stresses that fatal food-allergic reactions are rare but preventable, and that patients should carry up-to-date epinephrine devices and use them immediately during reactions. Air pollution and PM2.5 (Priority: 4/5): Nadeau explains PM2.5 as fine particulate air pollution that penetrates lungs and blood, contributes to cardiovascular, lung, stroke, and cancer risk, and can be monitored and mitigated with filters and masks.

Key Arguments: The immune system is highly effective at recognizing and eliminating pathogens through coordinated cellular and humoral responses, but the same machinery can misfire in allergy. IgE is normally useful against parasites but becomes the key driver of allergic disease when it binds food antigens and triggers mast cells to release histamine and bradykinin. Food sensitivity is not the same as food allergy; it may involve inflammation or intolerance pathways without the rapid, life-threatening IgE response seen in anaphylaxis. Celiac disease is a distinct, diagnosable immune disorder with genetic associations and a specific reaction to wheat proteins, not simply a generic wheat sensitivity. Most food allergy risk is environmental rather than genetic, with skin barrier disruption, detergents, pollution, low vitamin D, and limited early dietary exposure all contributing. Early and regular oral exposure to allergenic foods can promote immune tolerance, whereas avoidance in infancy may increase later allergy risk. Oral immunotherapy works by giving tiny, carefully escalated daily doses of the allergen to shift immune memory away from IgE and toward protective IgG/IgA responses. Patients with food allergy should carry current epinephrine devices, know how to use them quickly, and replace expired or outgrown doses. PM2.5 is a major, underappreciated health threat because it is small enough to enter the bloodstream and carries many toxic compounds from combustion and wildfire smoke. Air pollution exposure is not just an annoyance; it has measurable, population-level mortality effects and should influence daily behavior, exercise, and home filtration choices.

Data Points: IgE proportion of blood immunoglobulins: 0.005% - Nadeau describes IgE as the least abundant but most potent immunoglobulin class. Children with doctor-diagnosed food allergy: 1 in 12 - Cited from colleague Ruchi Gupta’s U.S. epidemiology data. Adults with food allergy: 1 in 30 - Estimated adult prevalence mentioned in the discussion. Milk/egg allergy resolution in young children (historical estimate): 80% chance of outgrowing by teenage years - Older teaching for children under age five. Milk/egg allergy resolution in young children (current estimate): 50% chance of outgrowing - Updated estimate reflecting more recent data. Food allergy deaths: About 1 per month in the U.S. - Nadeau’s rough estimate from cases she learns about. Food allergy immunotherapy starting dose: About 1/200th of a peanut - Initial oral immunotherapy dose described for peanut desensitization. Dose escalation: Increase by 25% every two weeks - Typical early oral immunotherapy titration schedule. Maintenance target: About 1 to 2 peanuts per day - Approximate end-of-protocol maintenance dose. FDA threshold referenced: 600 mg - Target accidental-ingestion protection threshold discussed. Chance of cure after 2 years of therapy: 20% - Probability of being able to stop therapy and eat ad lib without allergy after two years. Chance of cure after 5 years of therapy: 60% - Probability of durable cure after longer treatment duration. Need for epinephrine during immunotherapy: ~1 in 10,000 to 1 in 100,000 - Serious reactions during modern low-and-slow protocols are rare. PM2.5 size: 2.5 microns - Fine particulate matter small enough to penetrate lungs and enter blood. Air pollution mortality: 8 to 10 million deaths per year - Nadeau cites recent WHO/AQLI reporting on global mortality attributable to air pollution. Indoor time: >90% of life - Average U.S. time spent indoors, used to justify indoor air monitoring. MERV filter recommendation: MERV 13 or higher - Suggested HVAC filtration level for reducing PM2.5 and pollen exposure. Exercise air-quality caution: Avoid exercise when AQI > 50 - Nadeau advises limiting outdoor exercise on polluted days.

Pivotal Quotes: "I promised that father that I would do the absolute best to prevent further deaths in children and adults with food allergy." — Dr. Keri Nadeau: Explaining the personal origin of her commitment to food allergy research after a child died from milk allergy. "I call it the match that lights the fire behind allergies." — Dr. Keri Nadeau: Describing IgE’s role as the central trigger of allergic reactions. "If you have a peanut allergy and you don't carry an EpiPen, you can end up losing your life." — Peter Atiyah: Framing the clinical seriousness of food allergy and the need for emergency preparedness.

Implications: Food allergy is increasingly treatable, not just manageable: early exposure, barrier care, and oral immunotherapy can reduce risk and severity. Air pollution is also a major modifiable health threat, making monitoring, filtration, and behavior changes important.